Home
About
FAQ
History (3)
Mechanism of Action and Target Identification: A Matter of Timing in Drug Discovery.
NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance.
Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mechanism of Action and Target Identification: A Matter of Timing in Drug Discovery.
Davis RL. Mechanism of Action and Target Identification: A Matter of Timing in Drug Discovery. iScience. 2020 Aug 21; 23(9):101487.
View in:
PubMed
authors with profiles
Ronald L. Davis MD